Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development and applications of mRNA treatment based on lipid nanoparticles
Zhe Wang, Wanting Ma, Xingxing Fu, et al.
Biotechnology Advances (2023) Vol. 65, pp. 108130-108130
Closed Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Nanotechnology’s frontier in combatting infectious and inflammatory diseases: prevention and treatment
Yujing Huang, Xiaohan Guo, Yi Wu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 109
Recent progress in mRNA cancer vaccines
Ruhui Yao, C. Xie, Xiaojun Xia
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 31
The quest for nanoparticle-powered vaccines in cancer immunotherapy
Zhe Sun, Hui Zhao, Li Ma, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 23
Neoantigen vaccine nanoformulations based on Chemically synthesized minimal mRNA (CmRNA): small molecules, big impact
Saber İmani, Oya Tagit, Chantal Pichon
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 12
mRNA therapies: Pioneering a new era in rare genetic disease treatment
Guobo Shen, Jian Liu, Hanmei Yang, et al.
Journal of Controlled Release (2024) Vol. 369, pp. 696-721
Closed Access | Times Cited: 11
Development of mRNA Lipid Nanoparticles: Targeting and Therapeutic Aspects
Yaping Liu, Yingying Huang, Guantao He, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 10166-10166
Open Access | Times Cited: 8
Lipid nanoparticle (LNP) mediated mRNA delivery in cardiovascular diseases: Advances in genome editing and CAR T cell therapy
Setareh Soroudi, Mahmoud Reza Jaafari, Leila Arabi
Journal of Controlled Release (2024) Vol. 372, pp. 113-140
Closed Access | Times Cited: 6
Roadmap to discovery and early development of an mRNA loaded LNP formulation for liver therapeutic genome editing
Annette Bak, Liping Zhou, Joanna Rejman, et al.
Expert Opinion on Drug Delivery (2025)
Closed Access
Glucocorticoid pre-administration improves LNP-mRNA mediated protein replacement and genome editing therapies
Li Li, Mei Luo, Lifang Zhou, et al.
International Journal of Pharmaceutics (2025), pp. 125282-125282
Closed Access
Interleukin-35 mRNA therapy for influenza virus-induced pneumonia in mice
Yanyan Li, Yuqin Liao, Yiqi Miao, et al.
European Journal of Pharmacology (2025), pp. 177366-177366
Closed Access
Advances in Lipid Nanoparticle‐Based Disease Treatment
Yujie Zhou, Qiqi Ge, Xin Wang, et al.
ChemMedChem (2025)
Closed Access
Landscape of small nucleic acid therapeutics: moving from the bench to the clinic as next-generation medicines
Mohan Liu, Yusi Wang, Yi-Bing Zhang, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Mechanisms and research advances in mRNA antibody drug-mediated passive immunotherapy
Yuxiang Zhao, Linchuan Gan, Dangjin Ke, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 14
Incorporation of poly(γ-glutamic acid) in lipid nanoparticles for enhanced mRNA delivery efficiency in vitro and in vivo
Hongqian Zhang, Xue Gao, Qian Sun, et al.
Acta Biomaterialia (2024) Vol. 177, pp. 361-376
Open Access | Times Cited: 4
Development and applications of lipid hydrophilic headgroups for nucleic acid therapy
Wanting Ma, Xingxing Fu, Tianyi Zhao, et al.
Biotechnology Advances (2024) Vol. 74, pp. 108395-108395
Closed Access | Times Cited: 4
An overview of lipid constituents in lipid nanoparticle mRNA delivery systems
Shiqi Wu, Lixin Lin, Lu Shi, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 4
Closed Access | Times Cited: 4
Engineered mRNA Delivery Systems for Biomedical Applications
Ji Wang, Haofang Zhu, Jingjing Gan, et al.
Advanced Materials (2023) Vol. 36, Iss. 15
Closed Access | Times Cited: 9
Emerging mRNA Technology for Liver Disease Therapy
Ji Wang, Yile Fang, Zhiqiang Luo, et al.
ACS Nano (2024) Vol. 18, Iss. 27, pp. 17378-17406
Closed Access | Times Cited: 2
Golden Threads of Lipid Nanoparticles (LNPs) contributing to COVID-19 mRNA Vaccine: A Review
Mahanthi Vasu, Pinaj Yadav, Yalakala Satyanarayana, et al.
BioNanoScience (2024) Vol. 14, Iss. 3, pp. 3430-3439
Closed Access | Times Cited: 2
Simplified Lipid Nanoparticles for Tissue‐ And Cell‐Targeted mRNA Delivery Facilitate Precision Tumor Therapy in a Lung Metastasis Mouse Model
Yuan Fei, Xiaolu Yu, Peiyu Liu, et al.
Advanced Materials (2024)
Open Access | Times Cited: 2
Advances in Nanomaterials for Drug Delivery
Bancha Yingngam
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2023), pp. 22-85
Closed Access | Times Cited: 7
Innovative Strategies to Enhance mRNA Vaccine Delivery and Effectiveness: Mechanisms and Future Outlook
Abhishek Verma, Ankit Awasthi
Current Pharmaceutical Design (2024) Vol. 30, Iss. 14, pp. 1049-1059
Closed Access | Times Cited: 1
Nanomaterial-based cancer immunotherapy: enhancing treatment strategies
Mengxiang Tian, Xionglin Liu, Haiping Pei
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 1
A nucleoside-modified rabies mRNA vaccine induces long-lasting and comprehensive immune responses in mice and non-human primates.
Yu Wang, Shen Wang, Lulu Huang, et al.
Molecular Therapy (2024)
Closed Access | Times Cited: 1
Nanotechnology boosts the efficiency of tumor diagnosis and therapy
Ying Yang, Mali Lin, Mengfan Sun, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top